271 related articles for article (PubMed ID: 19182316)
21. The clinical characteristics of renal cell carcinoma in female patients.
Chen J; Shi B; Zhang D; Jiang X; Xu Z
Int J Urol; 2009 Jun; 16(6):554-7. PubMed ID: 19456990
[TBL] [Abstract][Full Text] [Related]
22. Renal cell carcinoma co-existent with other renal disease: clinico-pathological features in pre-dialysis patients and those receiving dialysis or renal transplantation.
Peces R; Martínez-Ara J; Miguel JL; Arrieta J; Costero O; Górriz JL; Picazo ML; Fresno M
Nephrol Dial Transplant; 2004 Nov; 19(11):2789-96. PubMed ID: 15316098
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study on incidental renal cell carcinoma].
Yamaguchi K; Tominaga T; Nishimura Y
Hinyokika Kiyo; 1995 Feb; 41(2):93-9. PubMed ID: 7702013
[TBL] [Abstract][Full Text] [Related]
24. Renal cell carcinoma in dialysis patients: a single center experience.
Kojima Y; Takahara S; Miyake O; Nonomura N; Morimoto A; Mori H
Int J Urol; 2006 Aug; 13(8):1045-8. PubMed ID: 16903927
[TBL] [Abstract][Full Text] [Related]
25. Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the National Cancer Data Base, 1993 to 2004.
Cooperberg MR; Mallin K; Ritchey J; Villalta JD; Carroll PR; Kane CJ
J Urol; 2008 Jun; 179(6):2131-5. PubMed ID: 18423754
[TBL] [Abstract][Full Text] [Related]
26. Renal cell cancer stage migration: analysis of the National Cancer Data Base.
Kane CJ; Mallin K; Ritchey J; Cooperberg MR; Carroll PR
Cancer; 2008 Jul; 113(1):78-83. PubMed ID: 18491376
[TBL] [Abstract][Full Text] [Related]
27. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
28. Pathological features of renal neoplasms classified by size and symptomatology.
Schlomer B; Figenshau RS; Yan Y; Venkatesh R; Bhayani SB
J Urol; 2006 Oct; 176(4 Pt 1):1317-20; discussion 1320. PubMed ID: 16952619
[TBL] [Abstract][Full Text] [Related]
29. Urinary nuclear matrix protein 22 for diagnosis of renal cell carcinoma.
Kaya K; Ayan S; Gokce G; Kilicarslan H; Yildiz E; Gultekin EY
Scand J Urol Nephrol; 2005; 39(1):25-9. PubMed ID: 15764267
[TBL] [Abstract][Full Text] [Related]
30. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
31. [Colon cancer in Iceland 1955-2004. Study on epidemiology, histopathology and gender difference].
Snaebjörnsson P; Jónasson L; Jónsson T; Möller PH; Theodórs A; Jónasson JG
Laeknabladid; 2009 Jun; 95(6):423-30. PubMed ID: 19491407
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of renal cell carcinoma as incidental finding].
Yazaki T; Iiyama T; Sato S; Hata R; Amemiya H; Tomomasa H; Muramatsu H; Iizumi T; Toyoshima A; Umeda T
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):409-15. PubMed ID: 1875560
[TBL] [Abstract][Full Text] [Related]
33. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts.
Selle B; Furtwängler R; Graf N; Kaatsch P; Bruder E; Leuschner I
Cancer; 2006 Dec; 107(12):2906-14. PubMed ID: 17109448
[TBL] [Abstract][Full Text] [Related]
34. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
[TBL] [Abstract][Full Text] [Related]
35. Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.
Kawaciuk I; Hyrsl L; Dusek P; Jarolim L; Schmidt M; Kaliska V; Chocholaty M; Vesely S
Scand J Urol Nephrol; 2008; 42(5):406-11. PubMed ID: 18932106
[TBL] [Abstract][Full Text] [Related]
36. [Anal cancer in Iceland 1987-2003. A population based study].
Vietharsdóttir H; Moeller PH; Jóhannsson J; Jónasson JG
Laeknabladid; 2006 May; 92(5):365-72. PubMed ID: 16741319
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic and molecular findings in 75 clear cell renal cell carcinomas.
Kardas I; Mrózek K; Babinska M; Krajka K; Hadaczek P; Lubinski J; Roszkiewicz A; Kuziemska E; Limon J
Oncol Rep; 2005 May; 13(5):949-56. PubMed ID: 15809763
[TBL] [Abstract][Full Text] [Related]
38. Impact of gender in renal cell carcinoma: an analysis of the SEER database.
Aron M; Nguyen MM; Stein RJ; Gill IS
Eur Urol; 2008 Jul; 54(1):133-40. PubMed ID: 18160207
[TBL] [Abstract][Full Text] [Related]
39. Renal cell carcinoma: t1 and t2 signal intensity characteristics of papillary and clear cell types correlated with pathology.
Oliva MR; Glickman JN; Zou KH; Teo SY; Mortelé KJ; Rocha MS; Silverman SG
AJR Am J Roentgenol; 2009 Jun; 192(6):1524-30. PubMed ID: 19457814
[TBL] [Abstract][Full Text] [Related]
40. Renal cell carcinoma: assessment of key pathologic prognostic parameters and patient characteristics in 47,909 cases using the National Cancer Data Base.
Nese N; Paner GP; Mallin K; Ritchey J; Stewart A; Amin MB
Ann Diagn Pathol; 2009 Feb; 13(1):1-8. PubMed ID: 19118775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
